MAPT and neuroblastoma: To examine whether R-(−)-apomorphine or raloxifene could protect cells from p-tau, the neuroblastoma SH-SY5Y cells were treated with different doses of p-tau for 16–20 h before propidium iodide (PI) and fluorescein diacetate (FDA) staining and microscopic inspection.